NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) — Stock Price
NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) is currently trading at $0.10 USD, down 39.88% today. Over the past 52 weeks, shares have ranged between $0.07 and $2.49. This page tracks NewGenIvf Group Limited Class A Ordinary Shares's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see NIVF cash flow metrics.
NewGenIvf Group Limited Class A Ordinary Shares (NIVF) Stock Price Chart — Daily History & Trading Volume
The chart below tracks NewGenIvf Group Limited Class A Ordinary Shares's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
NewGenIvf Group Limited Class A Ordinary Shares Income Statement — Revenue, Profit & Earnings by Year
NewGenIvf Group Limited Class A Ordinary Shares's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $4.73 Million | $5.43 Million | $5.14 Million | $5.94 Million | $4.12 Million |
| Cost of Revenue | $3.77 Million | $3.61 Million | $3.45 Million | $4.41 Million | $3.09 Million |
| Gross Profit | $955.85K | $1.83 Million | $1.68 Million | $1.54 Million | $1.02 Million |
| Research & Development | — | — | — | — | — |
| SG&A | $10.49 Million | $2.78 Million | $1.62 Million | $1.10 Million | $801.33K |
| Total Operating Expenses | $11.68 Million | $2.99 Million | $2.52 Million | $1.14 Million | $826.02K |
| Operating Income | $-10.73 Million | $-1.16 Million | $-2.52 Million | $398.70K | $198.76K |
| EBITDA | $10.84 Million | $24.26K | $-2.52 Million | $725.69K | $587.01K |
| EBIT | $10.35 Million | $-182.00K | $-2.75 Million | $421.75K | $244.47K |
| Interest Expense | $616.42K | $778.66K | $46.18K | $77.76K | $88.29K |
| Income Before Tax | $9.73 Million | $-961.00K | $-690.85K | $343.99K | $156.18K |
| Income Tax Expense | — | $-487.00K | $-229.71K | $208.14K | $294.72K |
| Net Income | $9.88 Million | $-525.00K | $-690.85K | $458.67K | $-533.00 |
NewGenIvf Group Limited Class A Ordinary Shares Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes NewGenIvf Group Limited Class A Ordinary Shares's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $32.72 Million | $3.58 Million | $21.32 Million | $2.90 Million | $1.41 Million |
| Total Current Assets | $7.38 Million | $3.17 Million | $50.78K | $2.40 Million | $820.39K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | $11.88K | — | — | — |
| Net Receivables | $1.07 Million | $2.36 Million | $1.02 Million | $2.32 Million | $750.35K |
| Inventory | $335.36K | $80.81K | $126.26K | $46.91K | $41.27K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $6.74 Million | $5.06 Million | $5.72 Million | $2.80 Million | $2.33 Million |
| Total Current Liabilities | $2.37 Million | $2.72 Million | $2.24 Million | $2.56 Million | $2.07 Million |
| Long-term Debt | $4.10 Million | $2.33 Million | — | — | — |
| Net Debt | $4.11 Million | $2.57 Million | $1.58 Million | $424.49K | $897.20K |
| Total Stockholder Equity | $26.63 Million | $-1.05 Million | $15.60 Million | $563.11K | $-775.94K |
| Retained Earnings | $8.89 Million | $-985.99K | $-5.67 Million | $-591.54K | $-1.05 Million |
NewGenIvf Group Limited Class A Ordinary Shares Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how NewGenIvf Group Limited Class A Ordinary Shares generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-10.93 Million | $-8.26 Million | $-857.36K | $-527.12K | $1.43 Million |
| Capital Expenditures | $5.75 Million | $53.04K | $69.85K | $94.45K | $16.57K |
| Free Cash Flow | $-16.68 Million | $-8.32 Million | $-927.20K | $-621.58K | $1.42 Million |
| Investing Cash Flow | $-7.56 Million | $-53.05K | — | $-69.69 Million | $-16.57K |
| Financing Cash Flow | $18.99 Million | $8.68 Million | $-50.41 Million | $70.27 Million | $-1.54 Million |
| Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | $499.50K | $206.26K | $229.71K | $303.94K | $342.54K |
| Change in Cash | $300.88K | $403.64K | $-12.49K | $54.72K | $-77.43K |
NewGenIvf Group Limited Class A Ordinary Shares Earnings History — EPS Actual vs. Analyst Estimates
Track NewGenIvf Group Limited Class A Ordinary Shares's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 10, 2025 | 0.73 | 0.00 | — |
| May 15, 2025 | 0.00 | 0.00 | — |
| Dec 31, 2024 | -855.66 | — | — |
| Dec 05, 2024 | -0.04 | — | — |
| Dec 31, 2023 | -46153.05 | — | — |
| Sep 30, 2023 | 4217.09 | — | — |
| Jun 30, 2023 | 2838.50 | — | — |
| May 11, 2023 | 0.01 | — | — |